ACCESSION: MSBNK-SMB_Measured-HSA015P0502000
RECORD_TITLE: Characterized; LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0); LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL17_pos_9677': {'bp': 112987.0, 'sum': 640802.0}, 'EL18_pos_9653': {'bp': 110107.0, 'sum': 599028.0}, 'EL16_pos_9659': {'bp': 99145.0, 'sum': 567666.0}, 'EL02_pos_9743': {'bp': 87711.0, 'sum': 439711.0}, 'EL20_pos_9659': {'bp': 78950.0, 'sum': 468727.0}, 'EL01_pos_9652': {'bp': 75929.0, 'sum': 459363.0}, 'EL14_pos_9682': {'bp': 68675.0, 'sum': 380418.0}, 'EL15_pos_9693': {'bp': 68030.0, 'sum': 366785.0}, 'EL19_pos_9741': {'bp': 66169.0, 'sum': 397712.0}, 'EL08_pos_9659': {'bp': 65673.0, 'sum': 325922.0}, 'EL05_pos_9723': {'bp': 60478.0, 'sum': 370268.0}, 'EL09_pos_9671': {'bp': 60233.0, 'sum': 351885.0}, 'EL04_pos_9646': {'bp': 59516.0, 'sum': 341334.0}, 'EL21_pos_9689': {'bp': 48867.0, 'sum': 234573.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 502.293171
COMMENT: PRECURSOR_M/Z_STDEV 0.000199
COMMENT: PRECURSOR_IN_MS1 mz 502.293071; int 49.169; delta(ppm) 0.722164
COMMENT: PROPOSED_CHARGE_STATE +1; mz 503.295982; int 12.998; cor 0.688
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.215; C32H39NO4; [M+H]+; delta(ppm) -4.215160
COMMENT: PROPOSED_MF SevenGoldenRules 2.152; C26H40N5O3P; [M+H]+; delta(ppm) -2.152465
COMMENT: PROPOSED_MF SevenGoldenRules 0.515; C25H44NO7P; [M+H]+; delta(ppm) 0.514676
COMMENT: PROPOSED_MF SevenGoldenRules 2.577; C19H45N5O6P2; [M+H]+; delta(ppm) 2.577372
COMMENT: PROPOSED_MF SevenGoldenRules 3.810; C27H39N3O6; [M+H]+; delta(ppm) 3.810202
COMMENT: PROPOSED_MF MS-FINDER 3.191; C32H39NO4; [M+H]+; delta(ppm) -4.207031
COMMENT: PROPOSED_MF MS-FINDER 3.155; C25H44NO7P; [M+H]+; delta(ppm) 0.513253
COMMENT: PROPOSED_MF MS-FINDER 2.889; C28H35N7O2; [M+H]+; delta(ppm) 1.139089
COMMENT: PROPOSED_MF MS-FINDER 2.856; C24H43N3O6S; [M+H]+; delta(ppm) -2.909763
COMMENT: PROPOSED_MF MS-FINDER 2.759; C27H39N3O6; [M+H]+; delta(ppm) 3.801719
COMMENT: PROPOSED_MF MS-FINDER 2.734; C28H43N3OS2; [M+H]+; delta(ppm) 2.071608
COMMENT: PROPOSED_MF MS-FINDER 2.506; C18H44N7O5PS; [M+H]+; delta(ppm) -0.852086
COMMENT: PROPOSED_MF MS-FINDER 2.455; C13H31N19O3; [M+H]+; delta(ppm) 0.138510
COMMENT: PROPOSED_MF MS-FINDER 2.439; C12H45N11O4P2S; [M+H]+; delta(ppm) 1.205599
COMMENT: PROPOSED_MF MS-FINDER 2.410; C18H52N3O4PS3; [M+H]+; delta(ppm) 0.080429
COMMENT: PROPOSED_MF MS-FINDER 2.404; C21H35N13S; [M+H]+; delta(ppm) -0.226252
COMMENT: PROPOSED_MF MS-FINDER 2.394; C20H39N9O4S; [M+H]+; delta(ppm) 2.436371
COMMENT: PROPOSED_MF MS-FINDER 2.384; C19H45N5O6P2; [M+H]+; delta(ppm) 2.570943
COMMENT: PROPOSED_MF MS-FINDER 2.383; C26H40N5O3P; [M+H]+; delta(ppm) -2.149360
COMMENT: PROPOSED_MF MS-FINDER 2.361; C16H47N5O8S2; [M+H]+; delta(ppm) -1.612491
COMMENT: PROPOSED_MF MS-FINDER 2.352; C13H39N15O2S2; [M+H]+; delta(ppm) 1.071027
COMMENT: PROPOSED_MF MS-FINDER 2.342; C26H48NO2PS2; [M+H]+; delta(ppm) -1.216847
COMMENT: PROPOSED_MF MS-FINDER 2.328; C16H39N9O9; [M+H]+; delta(ppm) -2.545003
COMMENT: PROPOSED_MF MS-FINDER 2.323; C11H44N13O3PS2; [M+H]+; delta(ppm) -2.217421
COMMENT: PROPOSED_MF MS-FINDER 2.253; C12H35N15O7; [M+H]+; delta(ppm) 2.801135
COMMENT: PROPOSED_MF MS-FINDER 2.225; C11H36N17O4P; [M+H]+; delta(ppm) -3.149932
COMMENT: PROPOSED_MF MS-FINDER 2.210; C19H53NO5P2S2; [M+H]+; delta(ppm) 3.503465
COMMENT: PROPOSED_MF MS-FINDER 2.189; C20H47N5O3S3; [M+H]+; delta(ppm) 3.368893
COMMENT: PROPOSED_MF MS-FINDER 2.181; C16H49N5O6P2S; [M+H]+; delta(ppm) -4.140522
COMMENT: PROPOSED_MF MS-FINDER 2.157; C17H43N9O4S2; [M+H]+; delta(ppm) -4.275092
COMMENT: PROPOSED_MF MS-FINDER 2.139; C14H40N13O3PS; [M+H]+; delta(ppm) 4.494070
COMMENT: PROPOSED_MF MS-FINDER 2.135; C17H51N5O3S4; [M+H]+; delta(ppm) -3.342583
COMMENT: PROPOSED_MF MS-FINDER 2.131; C13H47N11OS4; [M+H]+; delta(ppm) 2.003546
COMMENT: PROPOSED_MF MS-FINDER 2.124; C12H43N11O6S2; [M+H]+; delta(ppm) 3.733657
COMMENT: PROPOSED_MF MS-FINDER 2.009; C17H59NO2S6; [M+H]+; delta(ppm) -2.410072
COMMENT: PROPOSED_MF MS-FINDER 1.953; C25H47N3OS3; [M+H]+; delta(ppm) -4.639850
COMMENT: PROPOSED_MF MS-FINDER 1.857; C20H55NO2S5; [M+H]+; delta(ppm) 4.301416
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2062.803; C25H44NO7P; [M+H]+; delta(ppm) 0.513253
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C25H44NO7P; [M+H]+; delta(ppm) 0.513253
COMMENT: PROPOSED_MF SIRIUS6_Sirius 113.695; C25H44NO7P; [M+H]+; delta(ppm) 0.513253
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C25H44NO7P; [M+H]+; delta(ppm) 0.513253
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.215; YWOCITMXHHTBAW-XSQXPFHXSA-N; [M+H]+; CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)O[C@H](CO)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.174; ROPRRXYVXLDXQO-XSQXPFHXSA-N; [M+H]+; CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.161; JPNPIRVRGLGTRE-YSKCIPFOSA-N; [M+H]+; CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.027; BAKUYTLDCVITBO-YSKCIPFOSA-N; [M+H]+; CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(=O)O[C@H](CO)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.218; DHCYSRSSYGONKZ-UHFFFAOYSA-N; [M+H]+; O=C(C=CC=1C=C(OC)C(O)=C(C1)CC=2C=CC=3C=CC=CC3C2)CC(=O)CCCCCC(C)CNC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.753; RWTNPBWLLIMQHL-UHFFFAOYNA-N; [M+H]+; Fexofenadine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.401; ROPRRXYVXLDXQO-XSQXPFHXSA-N; [M+H]+; LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.396; JPNPIRVRGLGTRE-YSKCIPFOSA-N; [M+H]+; LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.354; YWOCITMXHHTBAW-XSQXPFHXSA-N; [M+H]+; LysoPE(0:0/20:4(5Z,8Z,11Z,14Z))
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.349; BAKUYTLDCVITBO-YSKCIPFOSA-N; [M+H]+; LysoPE(0:0/20:4(8Z,11Z,14Z,17Z))
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.280; YVDJBQQJIDPRKP-MNXQIKTCNA-N; [M+H]+; Aflatrem;alpha,alpha-Dimethylallylpaspalinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.228; WCISYVSWAOUFIY-HJSHOVQRNA-N; [M+H]+; Paspalitrem A;3-Methyl-2-butenylpaspalinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.178; FNTKJPWOQYZZSM-LGTSKZSNSA-N; [M+H]+; (2R,4bS,6aS,12bS,12cR)-9-isopentenylpaxilline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.124; MXOIVWLOTRYIQC-HJSHOVQRNA-N; [M+H]+; Paspalitrem C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.124; ONMXSHAELZXSPO-LKXZLRKZNA-N; [M+H]+; beta-Aflatrem
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.107; SELHCSAKGVTRBZ-ZOUKQTFFSA-N; [M+H]+; Pyrrospirone I
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.100; GAPPHVJLWSRLAC-UHFFFAOYSA-N; [M+H]+; 13-ethenyl-5,7,9,11,13-pentamethyl-2-oxa-18-azahexacyclo[20.2.2.1?,??.0?,?.0??,??.0??,??]heptacosa-1(24),11,22,25-tetraene-15,17,19-trione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.052; LQHLZZKYYXMPRY-UHFFFAOYSA-N; [M+H]+; 3-{[2-(hydroxydiphenylmethyl)pyrrolidin-1-yl]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.820; XMGZBOIGRMYNPS-UHFFFAOYSA-N; [M+H]+; 2,5-dioxopyrrolidin-1-yl 18,22-dimethyldecacyclo[15.7.1.0?,?.0?,??.0?,??.0?,??.0?,?.0?,??.0??,??.0??,??]pentacosane-10-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.693; DHCYSRSSYGONKZ-UHFFFAOYSA-N; [M+H]+; 1-{4-hydroxy-3-methoxy-5-[(naphthalen-2-yl)methyl]phenyl}-11-methyl-12-(methylamino)dodec-1-ene-3,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.691; BTHURUKJKDWVOE-UHFFFAOYSA-N; [M+H]+; 6-ethyl-9-hydroxy-2-{[4-hydroxy-3-(3-oxopropoxy)phenyl]methyl}-6-[(N'-methylcarbamimidamido)methyl]cyclodec-4-yn-1-yl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.675; LFVHVVWRGMVCMW-UHFFFAOYSA-N; [M+H]+; 2-[(1-{1-[(tert-butoxy)carbonyl]pyrrolidine-2-carbonyl}-4-phenylpiperidin-4-yl)formamido]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.666; PKVHTCJYPKFPHM-UHFFFAOYSA-N; [M+H]+; 1-[2-({1-[(tert-butoxy)carbonyl]-4-phenylpiperidin-4-yl}formamido)-3-methylbutanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.410; NEHSMRMOOSXSBN-UHFFFAOYSA-N; [M+H]+; 3-[(4-benzylpiperazin-1-yl)(1-tert-butyl-1H-1,2,3,4-tetrazol-5-yl)methyl]-6-ethoxy-1,2-dihydroquinolin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.386; BQICZXSOXHCUPJ-UHFFFAOYSA-N; [M+H]+; 3-[1-({5-[4-(2-methoxyphenyl)piperazine-1-carbonyl]-1-azabicyclo[2.2.2]octan-2-yl}methyl)-1H-1,2,3-triazol-4-yl]aniline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.350; XECYIWLLQYXKTA-UHFFFAOYSA-N; [M+H]+; 1-{4-[(2-{[(tert-butoxy)carbonyl]amino}-3-phenylpropanamido)methyl]cyclohexanecarbonyl}pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.349; VKAGXPJDNNXJEH-UHFFFAOYSA-N; [M+H]+; 2-({4-[({1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}formamido)methyl]cyclohexyl}formamido)-3-phenylpropanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.254; OIAHDQSEULDJQY-UHFFFAOYSA-N; [M+H]+; 2-({4-[(2-{[(tert-butoxy)carbonyl]amino}-4-(methylsulfanyl)butanamido)methyl]cyclohexyl}formamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.254; TXEVBOKTOMFKQV-UHFFFAOYSA-N; [M+H]+; 2-({4-[(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)methyl]cyclohexyl}formamido)-4-(methylsulfanyl)butanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.254; XNDZYQFGEBMYMB-UHFFFAOYSA-N; [M+H]+; 2-({4-[(2-{[(tert-butoxy)carbonyl]amino}-4-(methylsulfanyl)butanamido)methyl]cyclohexyl}formamido)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.251; ZGCNXNXIDVOLGB-UHFFFAOYSA-N; [M+H]+; 2-({4-[(2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanamido)methyl]cyclohexyl}formamido)-4-(methylsulfanyl)butanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.176; GAPZQUHMQDIXFX-LKRZFURDNA-N; [M+H]+; N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.154; XIMMKRXXDKAOMK-XMUNNZNHNA-N; [M+H]+; N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GAPPHVJLWSRLAC-UHFFFAOYSA-N; [M+H]+; 13-ethenyl-5,7,9,11,13-pentamethyl-2-oxa-18-azahexacyclo[20.2.2.1?,??.0?,?.0??,??.0??,??]heptacosa-1(24),11,22,25-tetraene-15,17,19-trione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BAKUYTLDCVITBO-YSKCIPFOSA-N; [M+H]+; LysoPE(0:0/20:4(8Z,11Z,14Z,17Z))
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JPNPIRVRGLGTRE-YSKCIPFOSA-N; [M+H]+; LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BTHURUKJKDWVOE-UHFFFAOYSA-N; [M+H]+; 6-ethyl-9-hydroxy-2-{[4-hydroxy-3-(3-oxopropoxy)phenyl]methyl}-6-[(N'-methylcarbamimidamido)methyl]cyclodec-4-yn-1-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; ROPRRXYVXLDXQO-XSQXPFHXSA-N; [M+H]+; LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; YWOCITMXHHTBAW-XSQXPFHXSA-N; [M+H]+; LysoPE(0:0/20:4(5Z,8Z,11Z,14Z))
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.906; SELHCSAKGVTRBZ-ZOUKQTFFSA-N; [M+H]+; Pyrrospirone I
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; MXOIVWLOTRYIQC-HJSHOVQRNA-N; [M+H]+; Paspalitrem C
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; WCISYVSWAOUFIY-HJSHOVQRNA-N; [M+H]+; Paspalitrem A;3-Methyl-2-butenylpaspalinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; ONMXSHAELZXSPO-LKXZLRKZNA-N; [M+H]+; beta-Aflatrem
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.866; YVDJBQQJIDPRKP-MNXQIKTCNA-N; [M+H]+; Aflatrem;alpha,alpha-Dimethylallylpaspalinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; FNTKJPWOQYZZSM-LGTSKZSNSA-N; [M+H]+; (2R,4bS,6aS,12bS,12cR)-9-isopentenylpaxilline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.684; RWTNPBWLLIMQHL-UHFFFAOYNA-N; [M+H]+; Fexofenadine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.545; XMGZBOIGRMYNPS-UHFFFAOYSA-N; [M+H]+; 2,5-dioxopyrrolidin-1-yl 18,22-dimethyldecacyclo[15.7.1.0?,?.0?,??.0?,??.0?,??.0?,?.0?,??.0??,??.0??,??]pentacosane-10-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.486; XECYIWLLQYXKTA-UHFFFAOYSA-N; [M+H]+; 1-{4-[(2-{[(tert-butoxy)carbonyl]amino}-3-phenylpropanamido)methyl]cyclohexanecarbonyl}pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.472; VKAGXPJDNNXJEH-UHFFFAOYSA-N; [M+H]+; 2-({4-[({1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}formamido)methyl]cyclohexyl}formamido)-3-phenylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.443; DHCYSRSSYGONKZ-UHFFFAOYSA-N; [M+H]+; 1-{4-hydroxy-3-methoxy-5-[(naphthalen-2-yl)methyl]phenyl}-11-methyl-12-(methylamino)dodec-1-ene-3,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.421; LQHLZZKYYXMPRY-UHFFFAOYSA-N; [M+H]+; 3-{[2-(hydroxydiphenylmethyl)pyrrolidin-1-yl]methyl}-8a-methyl-decahydro-2H-spiro[naphtho[2,3-b]furan-5,2'-oxiran]-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.391; LFVHVVWRGMVCMW-UHFFFAOYSA-N; [M+H]+; 2-[(1-{1-[(tert-butoxy)carbonyl]pyrrolidine-2-carbonyl}-4-phenylpiperidin-4-yl)formamido]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.391; PKVHTCJYPKFPHM-UHFFFAOYSA-N; [M+H]+; 1-[2-({1-[(tert-butoxy)carbonyl]-4-phenylpiperidin-4-yl}formamido)-3-methylbutanoyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.261; GAPZQUHMQDIXFX-LKRZFURDNA-N; [M+H]+; N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.173; XIMMKRXXDKAOMK-XMUNNZNHNA-N; [M+H]+; N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.790; RWTNPBWLLIMQHL-UHFFFAOYSA-N; [M+H]+; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.974; ROPRRXYVXLDXQO-XSQXPFHXSA-N; [M+H]+; [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.140; YWOCITMXHHTBAW-XSQXPFHXSA-N; [M+H]+; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.667; BAKUYTLDCVITBO-YSKCIPFOSA-N; [M+H]+; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.667; JPNPIRVRGLGTRE-YSKCIPFOSA-N; [M+H]+; [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.515; YVDJBQQJIDPRKP-UHFFFAOYSA-N; [M+H]+; 19-hydroxy-4,5,24,24-tetramethyl-12-(2-methylbut-3-en-2-yl)-25,26-dioxa-7-azaheptacyclo[21.2.1.01,20.04,19.05,16.06,14.08,13]hexacosa-6(14),8,10,12,20-pentaen-22-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; WCISYVSWAOUFIY-UHFFFAOYSA-N; [M+H]+; 19-hydroxy-4,5,24,24-tetramethyl-11-(3-methylbut-2-enyl)-25,26-dioxa-7-azaheptacyclo[21.2.1.01,20.04,19.05,16.06,14.08,13]hexacosa-6(14),8(13),9,11,20-pentaen-22-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; PAGKVQGBMADPCS-XSQXPFHXSA-N; [M+H]+; [(2R)-2,3-dihydroxypropyl] 2-[[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]amino]ethyl hydrogen phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -12.879; ROPRRXYVXLDXQO; [M+H]+; LPE(20:4omega6/0:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -34.385; JPNPIRVRGLGTRE; [M+H]+; Lysophosphatidylethanolamine(20:4n3/0:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.601; YWOCITMXHHTBAW; [M+H]+; LPE[0:0/20:4(omega-6)] zwitterion
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.570; BAKUYTLDCVITBO; [M+H]+; 1-hydroxy-2-eicsoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.295; PAGKVQGBMADPCS; [M+H]+; Glycerophospho-N-Arachidonoyl Ethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.287; ROPRRXYVXLDXQO; [M+H]+; LPE(20:4omega6/0:0)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -148.421; ROPRRXYVXLDXQO; [M+H]+; 1-Arachidonoyl-Sn-Glycero-3-Phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.468; YWOCITMXHHTBAW; [M+H]+; (2-aminoethoxy)[3-hydroxy-2-(icosa-5,8,11,14-tetraenoyloxy)propoxy]phosphinic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.991; SOFGMCJQWLTKCE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.520; JPNPIRVRGLGTRE; [M+H]+; (2-aminoethoxy)[2-hydroxy-3-(icosa-8,11,14,17-tetraenoyloxy)propoxy]phosphinic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -302.496; BAKUYTLDCVITBO; [M+H]+; (2-aminoethoxy)[3-hydroxy-2-(icosa-8,11,14,17-tetraenoyloxy)propoxy]phosphinic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -450.483; PAGKVQGBMADPCS; [M+H]+; Glycerophospho-N-Arachidonoyl Ethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.440; ROPRRXYVXLDXQO; [M+H]+; 1-Arachidonoyl-Sn-Glycero-3-Phosphoethanolamine
COMMENT: CONFIDENCE Level 3: Tentative candidate, LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0), ROPRRXYVXLDXQO-XSQXPFHXSA-N; Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (2), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0011517;
CH$NAME: LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0)
CH$NAME: [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C25H44NO7P
CH$EXACT_MASS: 501.285540
CH$SMILES: CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OCCN)O
CH$IUPAC: InChI=1S/C25H44NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26/h6-7,9-10,12-13,15-16,24,27H,2-5,8,11,14,17-23,26H2,1H3,(H,29,30)/b7-6-,10-9-,13-12-,16-15-/t24-/m1/s1
CH$LINK: CHEBI CHEBI:64395
CH$LINK: HMDB HMDB0011517
CH$LINK: INCHIKEY ROPRRXYVXLDXQO-XSQXPFHXSA-N
CH$LINK: LIPIDMAPS LMGP02050009
CH$LINK: PUBCHEM CID:42607465
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 15.744
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 502.293072
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-9404000000-4889436753c009b05b5b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180582 47.4147 55.018766 1.1087 7.18 0.6993 12 f{C3H3O1}/3.95ppm,p-C22H42N1O6P1
  55.0544615 110.8284 55.055169 0.8174 22.03 0.9385 14 f{C4H7}/4.27ppm,p-C21H38N1O7P1
  57.0337375 87.9276 57.034454 1.1923 21.42 0.8297 13 f{C3H5O1}/4.32ppm,p-C22H40N1O6P1
  57.0700868 41.7602 57.070803 1.2967 12.68 0.1259 12 f{C4H9}/3.68ppm,p-C21H36N1O7P1
  67.0544006 334.5317 67.055142 0.2983 36.26 0.8989 14 f{C5H7}/2.59ppm,p-C20H38N1O7P1
  69.0700070 106.3927 69.070750 1.0859 17.36 0.9231 13 f{C5H9}/1.89ppm,p-C20H36N1O7P1
  79.0543235 282.2020 79.055056 0.6704 34.09 0.8769 14 f{C6H7}/1.23ppm,p-C19H38N1O7P1
  81.0699450 243.7430 81.070671 0.8018 27.56 0.9473 14 f{C6H9}/0.84ppm,p-C19H36N1O7P1
  83.0855951 32.4310 83.086315 1.0953 8.99 0.6364 11 f{C6H11}/0.82ppm,p-C19H34N1O7P1
  86.0964616 97.2744 86.097168 1.0802 48.19 0.1545 11 f{C5H12N1}/0.42ppm,p-C20H33O7P1
  91.0541917 348.9996 91.054871 0.9335 42.24 0.9429 14 f{C3H10N1P1}/-3.78ppm,p-C22H35O7
  93.0698954 226.1458 93.070562 0.9670 40.02 0.8374 14 f{C7H9}/0.20ppm,p-C18H36N1O7P1
  95.0855455 208.4014 95.086198 0.7782 20.43 0.9209 14 f{C7H11}/0.20ppm,p-C18H34N1O7P1
  97.0646878 51.5606 97.065325 1.5145 10.60 0.4965 12 f{C6H9O1}/-1.07ppm,p-C19H36N1O6P1
  105.0699126 209.3328 105.070476 0.9327 22.97 0.8462 14 f{C4H12N1P1}/-2.60ppm,p-C21H33O7
  107.0855604 106.8845 107.086103 1.1206 17.29 0.9455 11 f{C8H11}/0.31ppm,p-C17H34N1O7P1
  109.1011278 60.1315 109.101656 1.3107 10.35 0.7802 14 f{C8H13}/-0.45ppm,p-C17H32N1O7P1
  117.0698427 83.7804 117.070309 0.8627 8.65 0.7890 14 f{C5H12N1P1}/-2.93ppm,p-C20H33O7
  119.0855251 180.5566 119.085973 1.1672 22.60 1.0000 14 f{C5H14N1P1}/-2.61ppm,p-C20H31O7
  121.1011680 79.4300 121.101597 1.6598 17.23 0.7912 13 f{C9H13}/-0.07ppm,p-C16H32N1O7P1
  129.0696821 44.6622 129.070028 1.2939 9.65 0.8392 12 f{C6H12N1P1}/-3.90ppm,p-C19H33O7
  131.0854164 87.6962 131.085738 1.2435 17.66 0.8077 13 f{C6H14N1P1}/-3.20ppm,p-C19H31O7
  133.1010885 102.2074 133.101386 0.9992 15.33 0.7727 11 f{C6H16N1P1}/-2.99ppm,p-C19H29O7
  145.1012945 44.3377 145.101582 0.9511 6.84 0.7576 10 f{C7H16N1P1}/-1.32ppm,p-C18H29O7
  147.1167263 50.2623 147.117019 1.7877 10.60 0.6923 13 f{C7H18N1P1}/-2.78ppm,p-C18H27O7
  157.1011542 44.9607 157.101474 1.4449 8.95 0.6273 11 f{C8H16N1P1}/-2.11ppm,p-C17H29O7
  203.1794659 120.1283 203.179909 0.9056 23.48 0.8736 13 f{C11H26N1P1}/-1.33ppm,p-C14H19O7
  361.2736636 999.0000 361.274108 0.6311 0.00 0.9033 14 f{C19H40N1O3P1}/-1.02ppm,p-C6H5O4
  362.2772378 208.2662 362.277683 1.5237 21.22 0.6923 12 ?
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  55.018058 47.41 47
  55.054462 110.83 110
  57.033737 87.93 87
  57.070087 41.76 41
  67.054401 334.53 334
  69.070007 106.39 106
  79.054324 282.20 282
  81.069945 243.74 243
  83.085595 32.43 32
  86.096462 97.27 97
  91.054192 349.00 348
  93.069895 226.15 226
  95.085545 208.40 208
  97.064688 51.56 51
  105.069913 209.33 209
  107.085560 106.88 106
  109.101128 60.13 60
  117.069843 83.78 83
  119.085525 180.56 180
  121.101168 79.43 79
  129.069682 44.66 44
  131.085416 87.70 87
  133.101089 102.21 102
  145.101295 44.34 44
  147.116726 50.26 50
  157.101154 44.96 44
  203.179466 120.13 120
  361.273664 999.00 999
  362.277238 208.27 208
//
